Porosome Therapeutics, Inc.Porosome Therapeutics, Inc.
  • Home
  • ABOUT US
  • PLATFORM
  • PIPELINE
  • TEAM
  • NEWS
  • Contact
     
    Porosome Therapeutics, Inc.Porosome Therapeutics, Inc.
      • Home
      • ABOUT US
      • PLATFORM
      • PIPELINE
      • TEAM
      • NEWS
      • Contact
      1. Home
      2. NEWS
      3. "State of Science at Porosome Therapeutics, Inc. 2025”, an Introduction by Guillermo Marmol, CEO. Guests in Attendance: J. P. Morgan Executives

      "State of Science at Porosome Therapeutics, Inc. 2025”, an Introduction by Guillermo Marmol, CEO. Guests in Attendance: J. P. Morgan Executives


      "State of Science at Porosome Therapeutics, Inc. 2025”, an Introduction by Guillermo Marmol, CEO.  Guests in Attendance: J. P. Morgan Executives








      •  
      •  
      •  
      Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)
      From the Chairman's Desk (Feb. 23, 2026) Porosome Therapeutics Therapies
      From the CEO's DESK (2026)
      • Home
      • ABOUT US
      • PLATFORM
      • PIPELINE
      • TEAM
      • Contact
      Copyright © 2026 All rights reserved - Porosome Therapeutics, Inc.